Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, May 3 2022

Full Issue

Different Takes: Can The CDC Regain Public Trust?; Covid Is Still A Pandemic For Young Kids

Opinion writers weigh in on these covid issues.

Bloomberg: The CDC Needs Reform To Restore Public Trust After Covid-19 

For many years, the U.S. Centers for Disease Control and Prevention was known as the world’s preeminent public-health agency. No longer. During the pandemic, the CDC stumbled repeatedly. Accused of incompetence, overreach and muddled messaging, it is now in need of repair. Director Rochelle Walensky was right to order a review of the agency’s operations in early April. She shouldn’t shrink from significant reforms. (5/2)

Los Angeles Times: A Vaccine For Kids Under 5 Is Necessary To Make COVID Endemic 

Last week, Moderna became the first manufacturer to officially ask the Food and Drug Administration to approve its COVID vaccine for children under 6 years old. One of three companies with authorized COVID-19 vaccines in the United States, Moderna made the request a month after saying its data showed efficacy for two doses given to kids. This comes a few months after the FDA delayed its review of a vaccine for young children from Pfizer, which has not yet requested authorization, until that company collects more data. (Nina Shapiro, 5/1)

Chicago Tribune: The US Response To COVID-19 Hasn’t Been A Train Wreck. We’re Just Average

The COVID-19 pandemic has taken another turn with new variants BA.2 and BA.2.12.1, which are apparently more contagious but less severe than their predecessors, causing a new mini-wave of infections in the U.S. Nationally, cases are up, but deaths and hospitalizations remain relatively low for now. Amid what amounts to an emerging sixth wave, the U.S. has received disproportionate criticism at home and from international observers for its handling of the pandemic. But over recent months, events worldwide should dispel notions of exceptional American malfeasance. (Cory Franklin And Robert Weinstein, 5/2)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF